Therapies for Rare Mitochondrial Diseases Begin to See Traction
The approval of Reata Pharmaceuticals’ Skyclarys for Friedreich’s ataxia highlights progress being made in the treatment of rare mitochondrial diseases.
Therapies for Rare Mitochondrial Diseases Begin to See Traction Read More »
